[go: up one dir, main page]

AU2001255469A1 - Purification of ace inhibiting polypeptides containing vpp from milk - Google Patents

Purification of ace inhibiting polypeptides containing vpp from milk

Info

Publication number
AU2001255469A1
AU2001255469A1 AU2001255469A AU5546901A AU2001255469A1 AU 2001255469 A1 AU2001255469 A1 AU 2001255469A1 AU 2001255469 A AU2001255469 A AU 2001255469A AU 5546901 A AU5546901 A AU 5546901A AU 2001255469 A1 AU2001255469 A1 AU 2001255469A1
Authority
AU
Australia
Prior art keywords
milk
purification
polypeptides containing
ace inhibiting
inhibiting polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255469A
Other languages
English (en)
Inventor
Joseph M. Kobzeff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Technology LLC
Original Assignee
Monsanto Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology LLC filed Critical Monsanto Technology LLC
Publication of AU2001255469A1 publication Critical patent/AU2001255469A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001255469A 2000-04-21 2001-04-19 Purification of ace inhibiting polypeptides containing vpp from milk Abandoned AU2001255469A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19967500P 2000-04-21 2000-04-21
US60199675 2000-04-21
PCT/US2001/012672 WO2001081366A2 (fr) 2000-04-21 2001-04-19 Purification de polypeptides inhibiteurs de l'enzyme de conversion de l'angiotensine contenant le vpp du lait

Publications (1)

Publication Number Publication Date
AU2001255469A1 true AU2001255469A1 (en) 2001-11-07

Family

ID=22738540

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255469A Abandoned AU2001255469A1 (en) 2000-04-21 2001-04-19 Purification of ace inhibiting polypeptides containing vpp from milk

Country Status (2)

Country Link
AU (1) AU2001255469A1 (fr)
WO (1) WO2001081366A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101084004A (zh) * 2004-12-22 2007-12-05 帝斯曼知识产权资产管理有限公司 单个酶促步骤中的血压降低寡肽
WO2006114441A1 (fr) * 2005-04-28 2006-11-02 Dsm Ip Assets B.V. Hydrolysats proteiques abaissant la pression arterielle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
WO1996017054A1 (fr) * 1994-12-01 1996-06-06 Oklahoma Medical Research Foundation Technique et compositions permettant de reduire l'absorption de cholesterol

Also Published As

Publication number Publication date
WO2001081366A2 (fr) 2001-11-01
WO2001081366A3 (fr) 2002-05-16

Similar Documents

Publication Publication Date Title
IL159310A0 (en) Peptide-based compounds
AU2001282679A1 (en) System for dispensing portions of various substances
AU2001238108A1 (en) Single phase gels for the prevention of adhesions
AU2002239262A1 (en) Compositions of peptide crystals
AU2002309650A1 (en) Highly conserved proteins from gram-positive bacteria
AU5204799A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
AU1488501A (en) Methods of inhibiting metastasis
IL155360A0 (en) Processes for the isolation or purification of plavastatin and compositions containing plavastatin
AU1569501A (en) Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
AUPQ475599A0 (en) Inhibition of two-component transduction systems
AUPR007700A0 (en) Drinking vessel
AU2001255469A1 (en) Purification of ace inhibiting polypeptides containing vpp from milk
AU3566200A (en) Human signal transduction serine/threonine protein kinase
AUPQ596600A0 (en) Point of sale system
GB0101406D0 (en) Characterisation of membranes
AU1569401A (en) Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
AU2002364169A1 (en) Dual inhibition of sister chromatide separation at metaphase
AU2001255501A1 (en) Blood-pressure reducing polypeptides containing vpp derived from microorganisms
AU2001286584A1 (en) Inhibition of protein-protein interaction
AU2002220591A1 (en) Means for the identification of compounds capable of inhibiting karap-transduced signals
AU2001290852A1 (en) Inhibitors of rho c
IL123281A0 (en) Purification of liquids
GB0019350D0 (en) Protection of vessels
AU2001273847A1 (en) Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene
AU1415301A (en) Use of peptide